Necrosis: all 474 studies

Page 5 of 5. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.

• French Observatory Syndromes Tako-TsuboCompletedNCT01252004
• ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin ReloadingCompletedNCT01228227Phase 3
• FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization.Status unknownNCT01160900Phase 3
• An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip ReplacementTerminatedNCT01134445Phase 4
• AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance StudyActive, not recruitingNCT01107340Not applicable
• Antimicrobial Pulpotomy of Primary MolarsCompletedNCT01010451Phase 4
• Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)CompletedNCT01007279Phase 3
• Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade GliomasCompletedNCT00942760
• Tissue Characterization in Teeth Treated With a Regeneration ProtocolCompletedNCT00881907Early Phase 1
• Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic PasteCompletedNCT00881491Early Phase 1
• A Randomised Study to Compare Metal Ion Release and Long-term Performance of the Pinnacle™ Cup With a Ceramic-on-Metal or a Metal-on-Metal BearingTerminatedNCT00873444Phase 4
• A Single Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing SurgeryTerminatedNCT00872794Phase 4
• A Two Centre Study to Assess the Stability and Long-term Performance of the C-Stem™ AMT in a Total Primary Hip ReplacementTerminatedNCT00872573Phase 4
• Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip ReplacementTerminatedNCT00872547Phase 4
• A Single Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Ceramic-on-ceramic Bearing in Primary Total Hip ReplacementTerminatedNCT00872222Phase 4
• A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip ReplacementCompletedNCT00872066Phase 4
• Cormet Large Diameter Metal on Metal (LDMOM) Total Hip System (G030265)TerminatedNCT00867256Not applicable
• Avascular Necrosis (AVN) Long-Term Follow-upTerminatedNCT00833430
• Treatment of Osteonecrosis of the Femoral Head by Bone Marrow TransplantationCompletedNCT00821470Phase 1
• Retrospective Study of the Linear™ HipTerminatedNCT00764959
• Foundation Knee Study - RetrospectiveTerminatedNCT00764894
• Efficacy of the CLP® Hip - RetrospectiveTerminatedNCT00764842
• Cementless Alumina-Alumina Total Hip and HybridCompletedNCT00764530Not applicable
• A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip ArthroplastyCompletedNCT00757354Not applicable
• A Comparison of Two Different Surgical Techniques for Total Hip ResurfacingCompletedNCT00750984Not applicable
• Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac SurgeryCompletedNCT00733876Phase 1
• Post-PMA Approval Study: 10 Year Follow-Up IDE SubjectsCompletedNCT00721994
• AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or PrednisoneCompletedNCT00719147
• A Clinical Investigation of the Taperloc® Microplasty™ Hip SystemCompletedNCT00699309
• A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder SystemsWithdrawnNCT00699270
• A Clinical Investigation of the Balance® Microplasty™ Hip SystemCompletedNCT00699088
• A Clinical Investigation of the Copeland™ Humeral Resurfacing HeadTerminatedNCT00698750
• A Clinical Investigation of the M2a- Taper™ Hip SystemTerminatedNCT00698633
• A Clinical Investigation of the M2a- 38™ Hip SystemTerminatedNCT00698503
• A Clinical Investigation of ArComXL® Polyethylene in Total Hip ReplacementCompletedNCT00698152
• INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis TrialCompletedNCT00638976Phase 3
• Efficacy of Chlorexidine as Intracanal Medicament in Primary TeethStatus unknownNCT00624572Phase 2
• A Prospective Clinical Study On A Total Hip Resurfacing SystemCompletedNCT00604734Not applicable
• A Prospective Clinical Study On A Total Hip Resurfacing SystemCompletedNCT00603395Not applicable
• A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee SystemCompletedNCT00578994
• A Clinical Investigation of the C2a-Taper™ Acetabular SystemCompletedNCT00578851
• Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis SystemTerminatedNCT00546598Phase 4
• Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell CarcinomaCompletedNCT00509704
• The Influence of Bisphosphonates in the Oral Cavity in ChildrenCompletedNCT00402064
• ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"CompletedNCT00360386Phase 2
• Clinical Study Evaluating an Acetabular Cup System After Total Hip ReplacementCompletedNCT00306930Not applicable
• Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee ProsthesesTerminatedNCT00289081Not applicable
• Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation NecrosisCompletedNCT00285324
• Molecular Genetic Study of Avascular Necrosis of the Femoral HeadStatus unknownNCT00260897
• Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head NecrosisCompletedNCT00244400
• GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host DiseaseCompletedNCT00228839Phase 1
• Measurement of Bite Force in HumansCompletedNCT00223327
• A Randomised Multi-centre Study to Compare the Long-term Performance of the Future Hip to 3 Other Implants in Primary Total Hip ReplacementTerminatedNCT00208468Phase 3
• A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip ReplacementTerminatedNCT00208455Phase 4
• A Randomised Single Centre Study to Compare the Long-term Wear Characteristics of Marathon™ and Enduron™ Polyethylene Cup Liners in Primary Total Hip ReplacementCompletedNCT00208442Phase 4
• A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip ReplacementWithdrawnNCT00208429Phase 4
• A Randomised Single Centre Study to Compare the Long-term Performance of Acryloc™ and Palacos® R Bone Cements in Primary Total Hip ReplacementTerminatedNCT00208403Phase 4
• A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip ReplacementTerminatedNCT00208390Phase 4
• A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing SurgeryTerminatedNCT00208377Phase 4
• A Two Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Metal-on-Metal Bearing in Primary Total Hip ReplacementTerminatedNCT00208364Phase 4
• A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip ReplacementTerminatedNCT00208351Phase 3
• A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV DiseaseCompletedNCT00205231Not applicable
• Comparison of Hip Resurfacing to Large Femoral Head Total Hip ArthroplastyStatus unknownNCT00175487Not applicable
• Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic SyndromeCompletedNCT00111956Phase 2/3
• Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or LegCompletedNCT00019968Phase 2
• Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell DiseaseCompletedNCT00006130Not applicable
• Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or LegCompletedNCT00003789Phase 3
• A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's SarcomaCompletedNCT00002262Phase 1
• Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor AntagonistCompletedNCT00001475Phase 2
• A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity MelanomaCompletedNCT00001296Phase 3
• A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected PatientsCompletedNCT00001116Not applicable
• A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related ComplexCompletedNCT00001004Phase 2
• Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDSCompletedNCT00000646Phase 1
• Blocking Tumor Necrosis Factor in Ankylosing SpondylitisCompletedNCT00000433Phase 2

← Necrosis overview